SR (60mg) gliclazide ,SR (500 mg) Metformin "''

gliclazide SR (60mg),Metformin SR (500 mg)
GLICLAGLAZE MET  
Gliclazide is an oral sulfonylurea medication used to lower blood sugar levels in people with type 2 diabetes. It stimulates the pancreas to release insulin, which helps cells in the body take up glucose (sugar) from the bloodstream. By increasing insulin production, gliclazide helps lower elevated blood sugar levels. It's important to note that gliclazide may cause hypoglycemia (low blood sugar) if not taken properly, so close monitoring of blood sugar levels and following medical advice is crucial.
Metformin is an oral biguanide medication commonly prescribed for type 2 diabetes. It works primarily by decreasing the amount of glucose produced by the liver and improving the sensitivity of muscle cells to insulin. Metformin does not stimulate insulin release like sulfonylureas do. Instead, it helps the body utilize insulin more effectively, which results in better control of blood sugar levels. Metformin is often considered a first-line treatment for type 2 diabetes due to its effectiveness and relatively low risk of causing hypoglycemia.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/gliclaglaze-met-133421